A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma.

CONCLUSION: The two-DNA methylation signature was deemed to be a potential novel prognostic biomarker of use in increasing the accuracy of predicting overall survival of ccRCC patients.
PMID: 31637882 [PubMed - in process]

Source: Yonsei Medical Journal - October 23, 2019 Category: Universities & Medical Training Authors: Shi S, Ye S, Wu X, Xu M, Zhuo R, Liao Q, Xi Y Tags: Yonsei Med J Source Type: research